$BYLT
Elite Performance Holding Corp

2022 Q1 Form 10-Q Financial Statement

#000147793223006737 Filed on September 08, 2023

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $285.00 $1.599K
YoY Change -82.18% -89.54%
Cost Of Revenue $6.443K $5.848K
YoY Change 10.17% -93.65%
Gross Profit -$6.158K -$4.249K
YoY Change 44.93% -94.46%
Gross Profit Margin -2160.7% -265.73%
Selling, General & Admin $0.00
YoY Change
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $550.8K $370.2K
YoY Change 48.77% 27.76%
Operating Profit -$556.9K -$374.5K
YoY Change 48.72% 2.17%
Interest Expense $25.11K $23.31K
YoY Change 7.7% -20.12%
% of Operating Profit
Other Income/Expense, Net -$25.11K -$23.31K
YoY Change 7.7% -20.12%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$582.0K -$397.8K
YoY Change 46.32% 0.52%
Net Earnings / Revenue -204218.95% -24876.49%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $41.82K $8.789K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $316.9K $10.13K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $368.0K $18.92K
YoY Change 1845.08%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $368.0K $18.92K
Total Long-Term Assets $0.00
Total Assets $18.92K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $619.0K
YoY Change
Accrued Expenses $111.5K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.483M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $201.4K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.483M
Total Long-Term Liabilities $201.4K
Total Liabilities $1.684M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$4.119M
YoY Change
Common Stock $9.195K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.732M -$1.665M
YoY Change
Total Liabilities & Shareholders Equity $18.92K
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$582.0K -$397.8K
YoY Change 46.32% 0.52%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$460.0K -$200.3K
YoY Change 129.69% -13.56%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $500.0K $208.8K
YoY Change 139.46% 226.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $500.0K $208.8K
YoY Change 139.46% -2.83%
NET CHANGE
Cash From Operating Activities -$460.0K -$200.3K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $500.0K $208.8K
Net Change In Cash $40.02K $8.537K
YoY Change 368.81% -150.8%
FREE CASH FLOW
Cash From Operating Activities -$460.0K -$200.3K
Capital Expenditures $0.00
Free Cash Flow -$460.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Assets Current
AssetsCurrent
10220 usd
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001753681
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107361300 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98971300 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2021Q3 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
105868 usd
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
000-55987
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Elite Performance Holding Corp.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5034226
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3301 NE 1st Ave Suite M704
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
CY2022Q1 dei City Area Code
CityAreaCode
844
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
426-2958
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
130001300 shares
CY2022Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
9250 usd
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
0 usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107361300 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
98971300 shares
CY2022Q1 us-gaap Revenues
Revenues
285 usd
CY2021Q1 us-gaap Revenues
Revenues
1599 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6443 usd
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5848 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-6158 usd
CY2021Q1 us-gaap Gross Profit
GrossProfit
-4249 usd
CY2022Q1 us-gaap Legal Fees
LegalFees
31046 usd
CY2021Q1 us-gaap Legal Fees
LegalFees
101903 usd
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
28774 usd
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
178206 usd
CY2022Q1 elite Consulting Expense
ConsultingExpense
416600 usd
CY2021Q1 elite Consulting Expense
ConsultingExpense
51830 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74341 usd
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38277 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
550761 usd
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
370216 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-556919 usd
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-374465 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
25105 usd
CY2021Q1 us-gaap Interest Expense
InterestExpense
23310 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25105 usd
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23310 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-582024 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-397775 usd
CY2022Q1 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2021Q1 elite Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2022Q1 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
102789744 shares
CY2021Q1 elite Basic And Diluted Weighted Average Number Of Share Outstanding
BasicAndDilutedWeightedAverageNumberOfShareOutstanding
65180344 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1628148 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
152100 usd
CY2021Q1 elite Shares Issued For Subscriptions Amount
SharesIssuedForSubscriptionsAmount
208800 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-397775 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1665023 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1988728 usd
CY2022Q1 elite Reg D Subscriptions Amount
RegDSubscriptionsAmount
500000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
339001 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-582024 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1731751 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-582024 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-397775 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1063 usd
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1049 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
339001 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
152100 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-308458 usd
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9250 usd
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
35900 usd
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
30333 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
63790 usd
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
14030 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-459978 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200263 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2021Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000 usd
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
208800 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500000 usd
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
208800 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40022 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8537 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1801 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41823 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8789 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2021Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2018Q1 us-gaap Shares Issued
SharesIssued
100000000 shares
CY2022Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
200000 shares
CY2022Q1 us-gaap Shares Issued
SharesIssued
400000 shares
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20000 usd
CY2022Q1 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
-5171956 usd
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
316877 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8419 usd
CY2022Q1 us-gaap Convertible Debt
ConvertibleDebt
545250 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
10905000 shares
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Revenues
Revenues
285 usd
CY2021Q1 us-gaap Revenues
Revenues
1599 usd
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5171956 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1086111 usd
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1086111 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1086111 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
963866 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1086111 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
963866 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20000 usd
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
465000000 shares
CY2022Q1 elite Description Of Shares Registered In The S1 Registration Statement
DescriptionOfSharesRegisteredInTheS1RegistrationStatement
the company has raised $1,250,000 (25,000,000 shares issued and 0 of shares to be issued) through a registered offering for $1,250,000 which was registered with the SEC through an S1 registration statement which went effective on April 23, 2019
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
35000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2020Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
201352 usd
CY2020Q2 elite Interest Rates
InterestRates
0.0098 pure
CY2020Q2 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
105868 usd
CY2019Q2 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
5000 usd
CY2019Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
152500 usd
CY2020Q2 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
201352 usd
CY2020Q2 elite Interest Rates
InterestRates
0.0098 pure
CY2020Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2022-04-23
CY2020Q2 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
105868 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
25105 usd
CY2022Q1 elite Intellectual Property And Patent Ownership For Shares
IntellectualPropertyAndPatentOwnershipForShares
22640000 shares

Files In Submission

Name View Source Status
0001477932-23-006737-index-headers.html Edgar Link pending
0001477932-23-006737-index.html Edgar Link pending
0001477932-23-006737.txt Edgar Link pending
0001477932-23-006737-xbrl.zip Edgar Link pending
elite-20220331.xsd Edgar Link pending
elite_10q.htm Edgar Link pending
elite_10qimg1.jpg Edgar Link pending
elite_10qimg2.jpg Edgar Link pending
elite_ex311.htm Edgar Link pending
elite_ex312.htm Edgar Link pending
elite_ex321.htm Edgar Link pending
elite_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
elite-20220331_def.xml Edgar Link unprocessable
elite-20220331_lab.xml Edgar Link unprocessable
elite-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elite_10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elite-20220331_cal.xml Edgar Link unprocessable